You have read all your free articles, to continue reading subscribe to read the rest of this content.
[vc_column_
Related Posts
Tony Hitchcock, Technical Director at Cobra Biologics, a Charles River Company, is joined by Karin Agerman, Chief Research and Development Officer at CombiGene, to explore the effects of the latest regulatory guidelines from both a CDMO and drug development perspective. As the scale and number ofAlready a subscriber Login You…
The emergence of new technologies at the forefront of new drug development, for example gene therapy, is driving a demand for tailor-made solutions and cutting-edge expertise throughout the biopharma industry. An increasing demand for needs-adapted molecular therapeutics is placing high demands on sAlready a subscriber Login You have read all…
For six months starting in January 2023 Sweden will hold the Presidency of the Council of the European Union. It is much more than an honorary role, encompassing an opportunity for Sweden to both set new guidelines and see to the implementation of important existing policies. The guiding documentAlready a…
Regulatory bodies and stakeholder organizations in drug and device manufacturing and distribution have long been working toward creating standards for temperature monitoring that ensure the shelf life, quality and safety of products. In the last 15 years of these ongoing efforts, mean kinetic temperAlready a subscriber Login You have read…